GRANULES price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- GRANULES
- MB Code
- MBEQU4151
- ISIN
- INE101D01020
- BSE code
- 532482
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 1470.61 Cr
- Net profit
- 201.57 Cr
- EPS
- 8.23
- YoY revenue
- +22.81%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for GRANULES
EPS 7.58 vs est. 7.21
Beat estimates by 5.13%
EPS 6.19 vs est. 6.18
Beat estimates by 0.16%
Granules India Ltd's board approved raising up to ₹1,760 crore, including ₹1,462.50 crore via convertible warrants and ₹300 crore through…
Granules India has received USFDA approval for its generic ADHD medication, Amphetamine extended-release orally disintegrating tablets, e…
EPS 5.38 vs est. 5.15
Beat estimates by 4.47%
Granules India Ltd reported a remarkable 191.40% increase in standalone net profit for the quarter ending September 2025, reaching Rs 120…
EPS 5.71 vs est. 5.46
Beat estimates by 4.60%
Dividend of ₹1.50 per share
Ex-date corporate action
Price returns
Historical performance
Technicals
Indicator consensus